These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21636966)

  • 1. Japanese guideline for allergic conjunctival diseases.
    Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Kumagai N; Satake Y; Shoji J; Nakagawa Y; Namba K; Fukagawa K; Fukushima A; Fujishima H;
    Allergol Int; 2011 Mar; 60(2):191-203. PubMed ID: 21636966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Japanese guidelines for allergic conjunctival diseases 2017.
    Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Kumagai N; Satake Y; Shoji J; Nakagawa Y; Namba K; Fukagawa K; Fukushima A; Fujishima H;
    Allergol Int; 2017 Apr; 66(2):220-229. PubMed ID: 28209324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japanese guidelines for allergic conjunctival diseases 2020.
    Miyazaki D; Takamura E; Uchio E; Ebihara N; Ohno S; Ohashi Y; Okamoto S; Satake Y; Shoji J; Namba K; Fukagawa K; Fukushima A; Fujishima H; ;
    Allergol Int; 2020 Jul; 69(3):346-355. PubMed ID: 33211650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Executive summary: Japanese guidelines for allergic conjunctival diseases 2021.
    Miyazaki D; Fukushima A; Uchio E; Shoji J; Namba K; Ebihara N; Takamura E; Fukuda K; Matsuda A; Okamoto S; Fukagawa K; Fujishima H; Ohno S; Ohashi Y;
    Allergol Int; 2022 Oct; 71(4):459-471. PubMed ID: 36096976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment.
    Ono SJ; Abelson MB
    J Allergy Clin Immunol; 2005 Jan; 115(1):118-22. PubMed ID: 15637556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of structural cells of the cornea and conjunctiva in the pathogenesis of vernal keratoconjunctivitis.
    Kumagai N; Fukuda K; Fujitsu Y; Yamamoto K; Nishida T
    Prog Retin Eye Res; 2006 Mar; 25(2):165-87. PubMed ID: 16427347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I; Gabrić N; Lazić R; Bosnar D; Cima I; Stipić A
    Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for ocular allergy.
    Leonardi A
    Expert Opin Emerg Drugs; 2005 Aug; 10(3):505-20. PubMed ID: 16083326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of novel scoring system named 5-5-5 exacerbation grading scale for allergic conjunctivitis disease.
    Shoji J; Inada N; Sawa M
    Allergol Int; 2009 Dec; 58(4):591-7. PubMed ID: 19776677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO; Onakoya AO; Olasimbo OO; Adefule AK
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of the early changes in ocular surface inflammation following MMC-aided papillary resection in severe allergic patients with corneal complications.
    Tanaka M; Dogru M; Takano Y; Miyake-Kashima M; Asano-Kato N; Fukagawa K; Tsubota K; Fujishima H
    Cornea; 2006 Apr; 25(3):281-5. PubMed ID: 16633027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergic conjunctivitis].
    Del Río-Navarro BE; Sienra-Monge JJ; Castellanos A; Williams-Gotti MJ
    Bol Med Hosp Infant Mex; 1992 Apr; 49(4):201-4. PubMed ID: 1305389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vernal keratoconjunctivitis.
    Bonini S; Coassin M; Aronni S; Lambiase A
    Eye (Lond); 2004 Apr; 18(4):345-51. PubMed ID: 15069427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vernal Keratoconjunctivitis: A Systematic Review.
    Bruschi G; Ghiglioni DG; Cozzi L; Osnaghi S; Viola F; Marchisio P
    Clin Rev Allergy Immunol; 2023 Aug; 65(2):277-329. PubMed ID: 37658939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of conjunctival epithelial cells in chronic ocular allergic disease.
    Hingorani M; Calder VL; Buckley RJ; Lightman SL
    Exp Eye Res; 1998 Nov; 67(5):491-500. PubMed ID: 9878210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of perilimbal conjunctival pigmentation in vernal conjunctivitis.
    Khan FA; Khan Niazi SP; Awan S
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):19-22. PubMed ID: 22237184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical picture, diagnosis and therapy of allergic eye diseases].
    Groblewska A
    Pol Merkur Lekarski; 2003 Jun; 14(84):719-22. PubMed ID: 14524317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominance of infiltrating IL-4-producing T cells in conjunctiva of patients with allergic conjunctival disease.
    Matsuura N; Uchio E; Nakazawa M; Yago T; Matsumoto S; Ohno S; Minami M
    Curr Eye Res; 2004; 29(4-5):235-43. PubMed ID: 15590468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of allergic eye diseases in primary eye care.
    Chigbu DI
    Cont Lens Anterior Eye; 2009 Dec; 32(6):260-72. PubMed ID: 19879797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.